Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
letter that demonstrates how you meet the following selection criteria: Essential: PhD in physics, astronomy, optics, atmospheric science, or a closely related field. Experience with adaptive optics
-
outputs of a team dedicated to translating discovery into meaningful impact for people living with Friedreich Ataxia. We are seeking someone with a PhD in computer engineering, biomedical engineering
-
of Cardiometabolic Medicine), Prof Paul Bannon (Cardiothoracic Surgeon and Professor of Cardiothoracic Surgery) and Dr Robert Hume (Lead of Translational Research). About you doctorate of PhD in a relevant field
-
AUSTRALIAN NATIONAL UNIVERSITY (ANU) | Canberra, Australian Capital Territory | Australia | about 2 months ago
PhD in seismology, geophysics, computer/data science, or planetary science. You will have demonstrated expertise in global seismology, particularly relating to the Earth’s core, core–mantle boundary
-
of these publications and your part in these. Selection Criteria: Essential PhD in Computer Science, Informatics, Data Science, Statistics, or a closely related area. Substantial research experience in applied Artificial
-
cutting-edge corneal imaging / Cultivate interdisciplinary collaborations Apply now for this unique opportunity to engage in innovative eye research Investing in you - benefits package including salary
-
and success of assigned research programs. Your key responsibilities will be to: Conduct research using human and mouse retinal tissue, including dissection, processing, primary culture, and molecular
-
on clinical trials, as well as contributing to the development of data-driven interventions and stewardship models to enhance patient outcomes after surgery. This position is an opportunity to work with a
-
, with demonstrated success in influencing clinical guidelines and generating significant academic and media engagement manage research ethics and governance processes, including trial registration, ethics
-
failure by amplifying the intrinsic regenerative potential of the human heart. These new therapeutics will be used to treat MI patients, enabling regeneration of cardiac muscle to reverse heart failure and